AD

Amitabha Datta

Director Director DIN 05112142
DIN 05112142 First appointment Jan 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2012
Shareholding value Locked Premium profile

About Amitabha Datta

Data last updated:

Amitabha Datta has 14 years in corporate governance. Formerly with 1 company, such as Swabhumi Drug & Pharmaceutical India Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05112142
Primary Designation Director
First Appointment 30 Jan 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director30 Jan 20122009Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Swabhumi Drug & Pharmaceutical India Limited
Premium access

Shareholding and investment profile for Amitabha Datta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amitabha Datta

Amitabha Datta has 14 years in corporate governance. Formerly with 1 company, such as Swabhumi Drug & Pharmaceutical India Limited. Engaged in General Business. Contributes to corporate operations.

Amitabha Datta is associated with 0 companies as a director.

Amitabha Datta has expertise in General Business.

Amitabha Datta has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available